ArticleAmerican journal of cancer research2017

Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer.

Yuping Yin et al.PubMed ↗Full text ↗

No numbers read from the abstract.